Craniopharyngioma: a case report and comparative galectin histochemical analysis
Language English Country Netherlands Media print
Document type Case Reports, Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Neoplasms, Basal Cell metabolism pathology MeSH
- Cell Differentiation physiology MeSH
- Adult MeSH
- Epithelium metabolism pathology MeSH
- Epitopes MeSH
- Phenotype MeSH
- Microscopy, Fluorescence MeSH
- Galectins metabolism MeSH
- Histocytochemistry MeSH
- Keratins metabolism MeSH
- Craniopharyngioma metabolism pathology MeSH
- Lectins MeSH
- Humans MeSH
- Antibodies, Monoclonal MeSH
- Biomarkers, Tumor MeSH
- Pituitary Neoplasms metabolism pathology MeSH
- Polysaccharides metabolism MeSH
- Carcinoma, Squamous Cell metabolism pathology MeSH
- Binding Sites MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
- Names of Substances
- Epitopes MeSH
- Galectins MeSH
- Keratins MeSH
- Lectins MeSH
- Antibodies, Monoclonal MeSH
- Biomarkers, Tumor MeSH
- Polysaccharides MeSH
Craniopharyngioma is a rare benign tumour originating from Rathke's pouch. This paper reports a tumour case studied with a set of markers defining protein-carbohydrate recognition. Expression of endogenous lectins and their reactive glycoligands is under differentiation-dependent control in many cell types. These parameters can be related to the degree of cell differentiation in tumours. Therefore, the expression patterns of endogenous lectins, namely galectins-1, -3, and -7, in the craniopharyngioma case were determined. Galectins-1 and -3 were also used to reveal glycoconjugates in cells and extracellular matrices, an approach that has heretofore relied largely on plant lectins. The staining pattern of craniopharyngioma is compared with that of two other types of ectodermally derived tumours, namely basal and squamous cell carcinomas. Clusters of polygonal and flattened cells with morphological characteristics of differentiated cells in the craniopharyngioma and the majority of poorly differentiated cells in squamous cell carcinomas were reactive with galectin-3. No binding of this probe was observed in cells of basal cell carcinomas and the majority of craniopharyngioma cells. In view of the lack of accessible binding in the basal layer of normal squamous epithelia where proliferative cells (including stem cells) are located, galectin-3 binding could be used to distinguish basal from suprabasal cells of squamous epithelial cells.
See more in PubMed
Am J Clin Pathol. 1999 May;111(5):623-31 PubMed
Int J Dev Biol. 1999 May;43(3):245-54 PubMed
Am J Clin Pathol. 1999 Aug;112(2):194-203 PubMed
Neuropathol Appl Neurobiol. 1999 Aug;25(4):319-30 PubMed
J Cancer Res Clin Oncol. 1999 Aug-Sep;125(8-9):461-74 PubMed
Cancer. 1999 Dec 1;86(11):2353-63 PubMed
Int J Mol Med. 2000 Apr;5(4):369-72 PubMed
Folia Biol (Praha). 1999;45(4):157-62 PubMed
J Biol Chem. 2000 Jun 2;275(22):16730-7 PubMed
East Mediterr Health J. 1999 May;5(3):490-502 PubMed
Naturwissenschaften. 2000 Mar;87(3):108-21 PubMed
Otolaryngol Head Neck Surg. 2000 Jun;122(6):834-41 PubMed
Arch Pathol Lab Med. 2000 Sep;124(9):1356-60 PubMed
Virchows Arch. 2000 Sep;437(3):284-92 PubMed
Cells Tissues Organs. 2001;168(1-2):5-23 PubMed
Anat Histol Embryol. 2001 Feb;30(1):3-31 PubMed
Int J Oncol. 2001 Jul;19(1):59-64 PubMed
J Biol Chem. 2001 Sep 21;276(38):35917-23 PubMed
J Biol Chem. 2002 Feb 1;277(5):3487-97 PubMed
Chembiochem. 2001 Nov 5;2(11):822-30 PubMed
Leukemia. 2002 May;16(5):840-5 PubMed
Cells Tissues Organs. 2002;171(2-3):135-44 PubMed
Biochim Biophys Acta. 2002 Sep 19;1572(2-3):285-93 PubMed
J Cell Biol. 1991 Nov;115(3):829-41 PubMed
J Craniofac Genet Dev Biol. 1985;5(1):89-104 PubMed
Cancer Invest. 1987;5(1):39-46 PubMed
No To Shinkei. 1994 Mar;46(3):271-6 PubMed
Int J Dev Biol. 1995 Jun;39(3):459-68 PubMed
Noshuyo Byori. 1993;10(2):131-4 PubMed
Exp Dermatol. 1994 Feb;3(1):9-16 PubMed
Biochemistry. 1996 May 14;35(19):6073-9 PubMed
Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6737-42 PubMed
AJNR Am J Neuroradiol. 1996 Sep;17(8):1427-39 PubMed
Eur J Biochem. 1997 Feb 1;243(3):543-76 PubMed
Histopathology. 1997 Feb;30(2):172-6 PubMed
Clin Neuropathol. 1997 Mar-Apr;16(2):103-6 PubMed
Cancer Invest. 1997;15(5):454-64 PubMed
Cancer Res. 1997 Dec 1;57(23):5272-6 PubMed
Eur J Oral Sci. 1998 Apr;106(2 Pt 1):667-70 PubMed
Differentiation. 1998 Jul;63(3):159-68 PubMed
Acta Anat (Basel). 1998;161(1-4):162-79 PubMed
J Immunol. 1999 Jan 15;162(2):799-806 PubMed